Subclinical Atherosclerosis

Identifying signs of asymptomatic atherosclerosis at the histological level is critical for diagnosing and treating patients. To prevent events related to the progression of coronary artery disease, which remains the primary cause of mortality, a further understanding of the early signs of atherosclerosis is crucial. Whereas thrombotic lesions continue to be a major focus in terms of treatment but are associated with significant morbidity and mortality, identifying and treating subclinical (undetected and asymptomatic) atherosclerosis through lifestyle and pharmacologic interventional should be an important focus. Subclinical atherosclerosis can be identified through various histological plaque morphologies, as well as calcification in the coronary arteries. 

Read more about this topic in CVPath’s recent work written by Kenji Kawai, Aloke Finn, and Renu Virmani and published in the January 2024 issue of Arteriosclerosis, Thrombosis, and Vascular Biology as a featured article.

Link: https://pubmed.ncbi.nlm.nih.gov/38150517/

Written by Gina Miller